Versant Capital Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-858
Closed -$9.49K 2733
2025
Q1
$9.49K Buy
+858
New +$9.49K ﹤0.01% 1745